| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Joseph H Wender is Director at OUT and has filed Form 4s across 2 companies. Joseph H Wender's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.8M at current prices.
Historically, Joseph H Wender's trades have earned a middling insider score of 57/100 across 6 rated trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +22.2%.
The biggest single holding is OUT (~$2.3M) as Director.
Joseph H Wender has 37 Form 4 filings on record from March 2015 to December 2025, across 2 companies: Director at Ionis Pharmaceuticals (IONS), 2019–2025; Director at OUTFRONT Media (OUT), 2015–2025.
The 81 reported transactions were 33 option exercises, 24 option or other derivative awards, 14 open-market sales and 9 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 6 sales worth about $9.5M.
The largest open-market sale was 28,000 shares of IONS at an average $80.82 on December 1, 2025, about $2.3M.
All 5 sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sell10b5-1 | 28,000 | $80.82 | $2,262,847.67 | -43.7% | -0.0% | - | |
| Oct 31, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sell10b5-1 | 28,000 | $74.02 | $2,072,577.59 | -30.4% | +12.9% | -40.3% | |
| Oct 1, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sell10b5-1 | 16,800 | $65.50 | $1,100,384.88 | -15.4% | +20.0% | -33.1% | |
| Sep 3, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sell10b5-1 | 28,000 | $57.58 | $1,612,155.44 | -20.5% | +34.4% | -3.9% | |
| Sep 3, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sell10b5-1 | 28,000 | $57.58 | $1,612,155.44 | -20.5% | +34.4% | -3.9% | |
| Mar 19, 2019 | IONS Ionis Pharmaceuticals Inc | Director | Sell | 10,000 | $79.63 | $796,258.00 | -14.5% | - | - |